Stay updated on Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab in advanced or metastatic acral lentiginous melanoma is available, with study details, eligibility criteria, treatment and outcome information, and a protocol document. The study is completed and is no longer recruiting participants.
    Difference
    41%
    Check dated 2026-11-09T13:22:39.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-02T13:18:01.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces the NIH websites transition and says agencies are adopting “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).
    Difference
    1%
    Check dated 2026-10-26T15:12:36.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:48:37.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T15:52:44.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden screen, replacing the prior study details with an access-restricted notice. This change blocks viewing the study record and its information on this URL.
    Difference
    17%
    Check dated 2026-09-21T22:10:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.